VANDE WEGHE PHARMA
0817.773.247 · rovalta.com · 25/09/2026
NORMAL SITUATION
VANDE WEGHE PHARMA
Company — Normal situation.
Financial year 2021 · Closed on 31/12/2021
Net result6,4 k €+143,7 %over 1 year
Gross margin13,3 k €+49,5 %over 1 year
Equity169,2 k €+4,6 %over 1 year
Overview
Identity
Source · BCE/KBOVANDE WEGHE PHARMA is a company registered in Belgium.
- Legal situation
- Normal situation
- BCE/KBO no. / VAT
- BE 0817.773.247
- Legal form
- Private company with limited liability
- Contributed capital
- 20 000,00 €
- Latest accounts
- 31/12/2021
Joint committees (1)
- 207
Signals
ProfitableSolid equityGood liquidityPositive cashflowPositive EBITDA
Financials
Source · NBB, 12 filingsTrend over 11 financial years
| 2021 | 2019 | 2018 | 2017 | 2016 | |||||
|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||
| Gross margin | 13,3 k € | +49.5% | 8,9 k € | +33.6% | 6,7 k € | -80.6% | 34,4 k € | -67.2% | 104,9 k € |
| EBITDA | 13 k € | +56.8% | 8,3 k € | +133% | -25,1 k € | -618% | -3,5 k € | -105% | 65,7 k € |
| Operating result | 6,6 k € | +329% | -2,9 k € | +91.4% | -33,8 k € | -157% | -13,1 k € | -123% | 57,5 k € |
| Net result | 6,4 k € | +144% | -14,7 k € | +62.6% | -39,3 k € | -103% | -19,4 k € | -151% | 37,8 k € |
| Balance sheet | |||||||||
| Equity | 169,2 k € | +4.6% | 161,7 k € | -8.3% | 176,5 k € | -18.2% | 215,8 k € | -8.2% | 235,1 k € |
| Total assets | 179,5 k € | -51.1% | 366,9 k € | -5.8% | 389,5 k € | +14.0% | 341,6 k € | -11.1% | 384,1 k € |
| Cash | 173,1 k € | -36.8% | 274,1 k € | -12.6% | 313,8 k € | +44.8% | 216,6 k € | +4.5% | 207,4 k € |
| Debts | 10,3 k € | -94.9% | 200,4 k € | -3.6% | 208 k € | +68.5% | 123,4 k € | -16.6% | 147,9 k € |
| Other | |||||||||
| Workforce | – | – | 0,1 ETP | – | – | ||||
Board of directors
Source · NBB, accounts to 31/12/20212 active · 5 ended
Active mandates
Lucrèce Van Goethem
ActiveGuy Vande Weghe
ActiveEnded mandates
Guy VANDE WEGHE
EndedLucrèce VAN GOETHEM
EndedGuy VANDE WEGHE
EndedGuy Vande Weghe
EndedFinancials
Full financial information
Source · NBB| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|
| Type of account | Micro model | Abridged model | Abridged model | Abridged model | Micro model | Micro model |
| Start of the financial year | 01/01/2021 | 01/01/2020 | 01/01/2019 | 01/01/2018 | 01/01/2017 | 01/01/2016 |
| Closing of the financial year | 31/12/2021 | 31/12/2020 | 31/12/2019 | 31/12/2018 | 31/12/2017 | 31/12/2016 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 12 months | 12 months |
| Filing date | 11/05/2022 | 20/08/2021 | 16/07/2020 | 29/08/2019 | 31/08/2018 | 28/07/2017 |
| General meeting | 21/02/2022 | 30/06/2021 | 26/06/2020 | 29/06/2019 | 30/06/2018 | 30/06/2017 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Source · NBBLooking for more information about this company?
Try for 7 daysAnnual accounts filings
Source · NBB, 12 filings| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Micro model | 31/12/2021 | 21/02/2022 | 11/05/2022 | Dutch | |
| Abridged model | 31/12/2020 | 30/06/2021 | 20/08/2021 | Dutch | |
| Abridged model | 31/12/2019 | 26/06/2020 | 16/07/2020 | Dutch | |
| Abridged model | 31/12/2018 | 29/06/2019 | 29/08/2019 | Dutch | |
| Micro model | 31/12/2017 | 30/06/2018 | 31/08/2018 | Dutch | |
| Micro model | 31/12/2016 | 30/06/2017 | 28/07/2017 | Dutch | |
| Abridged model | 31/12/2015 | 24/06/2016 | 31/08/2016 | Dutch | |
| Abridged model | 31/12/2014 | 26/06/2015 | 07/09/2015 | Dutch | |
| Abridged model | 31/12/2013 | 27/06/2014 | 27/07/2014 | Dutch | |
| Abridged model | 31/12/2012 | 28/06/2013 | 13/08/2013 | Dutch | |
| Abridged model | 31/12/2011 | 22/06/2012 | 25/06/2012 | Dutch | |
| Abridged model | 31/12/2010 | 24/06/2011 | 27/06/2011 | Dutch |
Valuation
Indicative valuation
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Disclaimer
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Source · NBB, accounts to 31/12/20212 active · 5 ended
Active mandates
Lucrèce Van Goethem
ActiveGuy Vande Weghe
ActiveEnded mandates
Guy VANDE WEGHE
EndedLucrèce VAN GOETHEM
EndedGuy VANDE WEGHE
EndedGuy Vande Weghe
EndedOwnership and network
Looking for more information about this company?
Try for 7 daysPublications
Similar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
- 2021Annual accounts 20216,4 k €↑
- 2019Annual accounts 2019-14,7 k €↑
- 2018Annual accounts 2018-39,3 k €↓
- 2017Annual accounts 2017-19,4 k €↓
- 2016Annual accounts 201637,8 k €↓
- 2015Annual accounts 201538,4 k €↓
- 2014Annual accounts 2014118,1 k €↑
- 2013Annual accounts 20133 k €↓
- 2012Annual accounts 20126,8 k €↑
- 2011Annual accounts 2011-2,8 k €↓
- 2010Annual accounts 201013,8 k €